RankAlpha logo
Back to Rankings

CSBR

Champions OncologyD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
CSBR vs peer average
55/100
CSBR vs. peer average (D vs. D)
Grade spread
B 1 · D 2 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

SERA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $79.88M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerSERASera Prognostics
CSBR
Champions Oncology
SERA
Sera Prognostics
Grade
D
F
Momentum
31
28
Value
62
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs SERA

CSBR / SERA
Grade Position
In line
CSBR vs. peer average (D vs. D)
55/100
Momentum
31
CSBR
Value
62
CSBR
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CSBR
1
SERA
Sera Prognostics Inc Class A Common
F
20/100
+1
2
BTMD
biote Corp Class A Common
D
40/100
Even
3
GANX
Gain Therapeutics Inc Common
B
80/100
-2
4
EXOZ
eXoZymes Inc Common
N/A
-
-
5
ACET
Adicet Bio Inc Common
F
20/100
+1
SERA is the first peer returned for this comparison set.